GenMark Diagnostics Analysis

GenMark Diagnostics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of GenMark Diagnostics delisted stock analysis is to determine its intrinsic value, which is an estimate of what GenMark Diagnostics is worth, separate from its market price. There are two main types of GenMark Diagnostics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect GenMark Diagnostics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of GenMark Diagnostics' stock to identify patterns and trends that may indicate its future price movements.
The GenMark Diagnostics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. GenMark Diagnostics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. GenMark Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GenMark Diagnostics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

GenMark Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.28. GenMark Diagnostics had not issued any dividends in recent years. GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the developing and commercializing molecular panels based on its proprietary eSensor electrochemical detection technology. The company was incorporated in 2010 and is headquartered in Carlsbad, California. Genmark Diagnostics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 618 people. To learn more about GenMark Diagnostics call Hany Massarany at 760 448-4300 or check out www.genmarkdx.com.

GenMark Diagnostics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GenMark Diagnostics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GenMark Diagnostics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
GenMark Diagnostics is not yet fully synchronised with the market data
GenMark Diagnostics has some characteristics of a very speculative penny stock
GenMark Diagnostics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 171.55 M. Net Loss for the year was (18.64 M) with profit before overhead, payroll, taxes, and interest of 67.94 M.
Over 95.0% of the company shares are owned by institutional investors

GenMark Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GenMark Diagnostics's market, we take the total number of its shares issued and multiply it by GenMark Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

GenMark Profitablity

GenMark Diagnostics' profitability indicators refer to fundamental financial ratios that showcase GenMark Diagnostics' ability to generate income relative to its revenue or operating costs. If, let's say, GenMark Diagnostics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GenMark Diagnostics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GenMark Diagnostics' profitability requires more research than a typical breakdown of GenMark Diagnostics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (10.87) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.11.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding GenMark Diagnostics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in GenMark Stock

If you are still planning to invest in GenMark Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GenMark Diagnostics' history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets